PLA results place tighter limits on the coincidence of P‐tau and dynactin signals in AD, noted above, and corroborate the data of Table 1 indicating enrichment of dynactins in tau‐IP aggregates prepared from AD but not AMC hippocampus. Here, MAPT is linked to Alzheimer disease.